Literature DB >> 11249799

Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex.

C M Moore1, J L Breeze, S A Gruber, S M Babb, B B Frederick, R A Villafuerte, A L Stoll, J Hennen, D A Yurgelun-Todd, B M Cohen, P F Renshaw.   

Abstract

OBJECTIVES: Alterations in choline and myo-inositol metabolism have been noted in bipolar disorder, and the therapeutic efficacy of lithium in mania may be related to these effects. We wished to determine the relationship between anterior cingulate cortex choline and myo-inositol levels, assessed using proton magnetic resonance spectroscopic imaging (MRSI), and mood state in subjects with bipolar disorder.
METHODS: Serial assessments of anterior cingulate cortex choline and myo-inositol metabolism were performed in nine subjects with bipolar disorder, taking either lithium or valproate, and 14 controls. Each bipolar subject was examined between one and four times (3.1 +/- 1.3). On the occasion of each examination, standardized ratings of both depression and mania were recorded.
RESULTS: In the left cingulate cortex, the bipolar subjects' depression ratings correlated positively with MRSI measures of Cho/Cr-PCr. In the right cingulate cortex, the Cho/Cr-PCr ratio was significantly higher in subjects with bipolar disorder compared with control subjects. In addition, bipolar subjects not taking antidepressants had a significantly higher right cingulate cortex Cho/Cr-PCr ratio compared with patients taking antidepressants or controls. No clinical or drug-related changes were observed for the Ino/Cr-PCr ratio.
CONCLUSIONS: The results of this study suggest that bipolar disorder is associated with alterations in the metabolism of cytosolic, choline-containing compounds in the anterior cingulate cortex. As this resonance arises primarily from phosphocholine and glycerophosphocholine, both of which are metabolites of phosphatidylcholine, these results are consistent with impaired intraneuronal signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11249799     DOI: 10.1034/j.1399-5618.2000.20302.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  31 in total

1.  Effect of diet on brain metabolites and behavior in spontaneously hypertensive rats.

Authors:  Ana A Liso Navarro; Elif M Sikoglu; Cailin R Heinze; Ryan C Rogan; Vivienne A Russell; Jean A King; Constance M Moore
Journal:  Behav Brain Res       Date:  2014-05-19       Impact factor: 3.332

Review 2.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

3.  Role of glia in prefrontal white matter abnormalities in first episode psychosis or mania detected by diffusion tensor spectroscopy.

Authors:  Kathryn E Lewandowski; Fei Du; Xiaoying Fan; Xi Chen; Polly Huynh; Dost Öngür
Journal:  Schizophr Res       Date:  2019-05-14       Impact factor: 4.939

4.  Neurochemical deficits in the cerebellar vermis in child offspring of parents with bipolar disorder.

Authors:  Manpreet K Singh; Daniel Spielman; Allison Libby; Elizabeth Adams; Tenah Acquaye; Meghan Howe; Ryan Kelley; Allan Reiss; Kiki D Chang
Journal:  Bipolar Disord       Date:  2011-03       Impact factor: 6.744

5.  Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.

Authors:  Nick C Patel; Melissa P DelBello; Kim M Cecil; Caleb M Adler; Holly S Bryan; Kevin E Stanford; Stephen M Strakowski
Journal:  Biol Psychiatry       Date:  2006-11-01       Impact factor: 13.382

6.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

7.  Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression.

Authors:  Kiki Chang; Melissa Delbello; Wen-Jang Chu; Amy Garrett; Ryan Kelley; Neil Mills; Meghan Howe; Holly Bryan; Cal Adler; Jim Eliassen; Daniel Spielman; Stephen M Strakowski
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-07-31       Impact factor: 2.576

8.  A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy.

Authors:  Tomas Hajek; Denise Bernier; Claire Slaney; Lukas Propper; Matthias Schmidt; Normand Carrey; Glenda MacQueen; Anne Duffy; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

9.  Anterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression: a potential new tool for diagnosis.

Authors:  Xian-Feng Shi; Lauren N Forrest; M Danielle Kuykendall; Andrew P Prescot; Young-Hoon Sung; Rebekah S Huber; Tracy L Hellem; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  J Affect Disord       Date:  2014-06-02       Impact factor: 4.839

10.  Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions.

Authors:  Pedro E M S Ferreira; André Palmini; Claiton H D Bau; Eugenio Horacio Grevet; João Rubião Hoefel; Luis Augusto Rohde; Maurício Anés; Eloisa Elena Ferreira; Paulo Belmonte-de-Abreu
Journal:  J Neural Transm (Vienna)       Date:  2009-04-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.